INS and Parkinson disease: In a randomized, double‐blind, placebo‐controlled trial, probiotics in patients with PD for 12 weeks improved biomarkers of inflammation, oxidative stress, and insulin metabolism and lowered values on the Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) in the intervention group.211